Secondary organizing pneumonia after recovery of mild COVID-19 infection

Review Immunology

COVID-19 in Immunocompromised Hosts: What We Know So Far

Monica Fung et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 has led to significant morbidity and mortality globally. The impact of the disease on immunosuppressed patients, such as cancer patients and transplant recipients, remains unclear. Further research is needed to determine the risk of COVID-19 severity and death in immunocompromised patients.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Jeroen J. A. van Kampen et al.

Summary: The study found that the median duration of shedding infectious virus in COVID-19 patients is 8 days, dropping below 5% after 15.2 days post onset of symptoms. High viral loads are associated with infectious SARS-CoV-2 isolation, while high serum neutralizing antibody titres are associated with non-infectious SARS-CoV-2.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Respiratory System

Severe organising pneumonia following COVID-19

Istvan Vadasz et al.

Summary: Various forms of diffuse parenchymal lung disease have been proposed as potential consequences of severe COVID-19, including severe organising pneumonia. Understanding these implications may help improve therapeutic modalities in the late-phase of severe COVID-19, and shed light on why a subgroup of patients benefit from systemic corticosteroids.

THORAX (2021)

Add to Collection

Letter Hematology